1、 Lin Gui, Xuehao Zhang, Zengying Qiao, Hao Wang. Cell-Penetrating peptides and polymers for improved drug delivery. ChemNanoMat. 2020, 6(8), 1138-1148.（IF 3.42） 2、 Gui L, Zhang X, Li K, et al. Evaluating p97 Inhibitor Analogues for Potency against p97–p37 and p97–Npl4–Ufd1 Complexes[J]. ChemMedChem, 2016, 11(9): 953-957. (IF 2.968) 3、Zhang X, Gui L, Zhang X, et al. Altered cofactor regulation with disease-associated p97/VCP mutations[J]. Proceedings of the National Academy of Sciences, 2015, 112(14): E1705-E1714. (IF 9.809) 4、Fang C J, Gui L, Zhang X, et al. Evaluating p97 inhibitor analogues for their domain selectivity and potency against the p97–p47 complex[J]. ChemMedChem, 2015, 10(1): 52-56. (IF 3.046) 5、Lin Gui, Ming Zhao, Yuji Wang, Yinye Wang, Yang Qin, Li Li, ShiqiPeng, Synthesis, nano-features, ex vivo anti-platelet aggregation and in vivo anti-thrombotic activities of poly-α,β-DL-aspartyl-L-arginine. MedChemComm. 2012, 3, 102-108. (IF 2.800) 6、Lin Gui, Ming Zhao, Yinye Wang, Yang Qin, Jiangyuan Liu, ShiqiPeng, Synthesis, nano- features, in vitro thrombus lysis activity and in vivo thrombolytic activity of poly-α,β-DL- aspartyl-L-alanine. Nanomedicine-UK, 2010, 5, 703 - 714. (IF 6.202)
|
